Canadian Cannabis Compendium


Herein we provide a detailed 2021 Year in Review for Canadian cannabis, breaking down LP performance and brand share across form factors and key provinces. We decrease our legal 2022 TAM by 1.8% to C$6.3 bn (including medical and taxes), primarily due to lower incidence and continued price deflation. We expect a highly fragmented adult-use market and price deflation to endure, suggesting continued consolidation opportunities in 2022.

Cannabis Investment Opportunities

From examining 2021 cannabis incidence rates along with retail and wholesale sales from Statistics Canada, supplemented with Hifyre data, we lower our 2021 Canadian legal TAM 1.8% to C$6.3 bn. In spite of the continued migration of consumption over from illicit channels, the lower incidence in 2021 along with the continued DD price deflation, coupled with an even more fragmented market, makes us remain more favorable on the U.S. market for investment opportunities.

Our proprietary model for the legal TAM in Canada, which came in within ~70 bps of the C$3.9 bn adult-use retail sales reported by Statistics Canada in 2021, is a bottom-up approach based on incidence rates, pricing, average consumption and illicit mix. Our 1.8% downward revision to our 2022 legal TAM is driven primarily from 2021 incidence data from Health Canada’s 2021 survey coming below our estimates by ~280 bps for past year and ~150 bps for past month.

Financial & Industry Model Implications

The continued deflationary environment has driven noticeable share gains for the legal market which we estimate was 56% in 2021. We expect these gains to continue as prices, specifically for flower, remain depressed, from increased value and larger format offerings, which in turn should drive incremental migration into the legal market.

Key Catalysts in 2022

We are watching a few things in 2022:

  1. increased consolidation in the market as LPs look to opportunistically increase overall or category-specific market share in a fragmented market
  2. continued rationalization on both the SKU and brand level, as well as the store level, as LPs look to right-size their cost structures and improve cost efficiency and store productivity
  3. the impact of the proposed increase of the purchase limit for beverages from 5 standard cans to 48 on both LPs that lead in the category  and category growth
Get the Full Report

If you’re already a member of our Research portal, log in.

Log In

If not, reach out to us directly for more information.

    More Like This

    marijuana field in Jamaica
    Ahead of the Curve®

    U.S. Cannabis Collective: A State by State Overview

    Read More >
    In the 5th episode of The Growth Chamber, Cowen Research's Vivien Azer offers a summary of the SXSW’s Cannabis Industry Evolution Summit. The concept for the image is the closing night of this marijuana show, hence a grow room foregrounded before a dark backdrop.

    Cowen’s SXSW Wrap-Up

    Read More >
    In the 4th episode of The Growth Chamber, Mary Bailey MD of the Last Prisoner Project discusses success stories & cannabis industry partners and their mission. The image is of a gavel and marijuana buds. Representative of the legal injustice perpetrated on cannabis users across the United States. Last Prisoner Project vows to correct this injustice.

    The Advocacy Landscape with Last Prisoner Project

    Read More >